Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
2,666.3
-3.2 (-0.12%)

 

  • STI Straits Times Index
    2,666.3
    -3.2 (-0.12%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,583.5
    -0.1
    Index delayed 15 minutes
  • HSI Hang Seng Index
    26,354.1
    224.9 (0.86%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,426.2
    22.8 (0.67%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    22,491.3
    52.6 (0.23%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    5,076.2
    -
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 642.9M
  • Value: 239.0M
  • Rise: 112
  • Fall: 86
  • Unch: 610

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
AsiaMedic0.034+0.014
QT Vascular0.006+0.001
Singapore-eDev0.134+0.001
3Cnergy0.020+0.003
Medtecs Intl0.880+0.060
Thomson Medical0.061+0.002
Healthway Med0.038+0.003
Adventus0.023+0.003
Clearbridge0.179+0.007
SingMedical0.265+0.010

World Indices

World Indices
Name Last Change
Nasdaq 9,757.2 -259.8
HSI 24,253.8 -296.2
HSCEI 9,745.8 -107.4
Jakarta 4,863.1 -41.0
Nikkei 225 22,064.8 -447.3
SSE Comp 2,959.0 -11.7
Shanghai A 3,101.5 -12.2
Shanghai B 211.6 -1.8
KOSPI 2,100.4 -34.3

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

YUNNAN ENERGY YUNNAN ENERGY
Quotes 15 Minutes Delayed. Updated at 09 Jul 2020 09:36
Last (HKD): 1.920 Change: - High: 1.920 Remarks: -
Change (%): - Low: 1.920
Open 1.920 Yesterday's Close 1.920
Buy Price 1.720 Sell Price 1.990
Buy Volume ('000) 1 Sell Volume ('000) 1
Cumulative Volume ('000) - Cumulative Value -
Click to show Stock Prices chart

Key Statistics

EPS (HKD) a -0.07186 Trailing EPS (HKD) e -0.07186 NAV (HKD) b 1.0191
PE a - Trailing PE f - Price / NAV b 1.8840
Dividend (HKD) d - Cash In Hand (HKD) g 0.1464 Issued & Paid-up Shares c 275,437,000
Dividend Yield (%) d - Price / Cash In Hand g 13.115 Treasury Shares h -
Beta - 75 Daysi -0.203 R-Squared - 75 Days(%)i 1.42 Market Cap (M) 528.839
Beta - 500 Daysi -0.018 R-Squared - 500 Days (%)i - Enterprise Value (M) 519.064
Piotroski F Score 3 Exchange Code 1298 Par Value ( USD ) 0.05000
52 Weeks Volatility (%) 45.15 6-Month VWAP 2.241 Free Float (%) 49.0
Sector & Industry Health Technology - Medical Specialties
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 03 Nov 2015.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 17 Sep 2015.
  9. Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference YUNNAN ENERGY HKEx 528.839 - - 1.8840 -
Industry Medical Specialties HKEx 18,188.786 115.667 115.667 6.9783 0.280
Local Peer WEIGAO GROUP HKEx 85,924.270 41.074 41.074 4.7460 0.699
Local Peer MICROPORT HKEx 71,289.270 196.590 196.595 17.6279 0.121
Local Peer KANGJI MEDICAL HKEx 44,015.181 213.211 213.206 134.5197 -
Local Peer VENUS MEDTECH-B HKEx 34,703.432 - - 10.2155 -
Local Peer AK MEDICAL HKEx 29,742.999 98.245 98.244 23.8265 0.265
Local Peer PEIJIA-B HKEx 22,278.714 - - -39.9093 -
Local Peer KDL MEDICAL HKEx 11,586.800 102.579 102.580 8.5157 0.279
Local Peer LIFETECH SCI HKEx 9,873.185 67.397 67.393 7.6612 -
Local Peer CIRC HKEx 6,717.371 18.005 18.005 1.5974 0.727
Local Peer YESTAR HEALTH HKEx 2,780.272 12.098 12.098 2.1196 -
Local Peer PW MEDTECH HKEx 2,652.032 28.528 28.529 0.5144 -
Local Peer GOLDEN MEDITECH HKEx 2,362.713 - - 0.6145 -
Other Local Peers VINCENT MED (HKEx), MODERN DENTAL (HKEx), KELFRED (HKEx), LIFE HEALTHCARE (HKEx), HUAKANG BIOMED (HKEx)
Global Peer ABBOTT LABORATORIES NYSE 163,760.133 44.670 46.273 5.4193 1.421
Global Peer THERMO FISHER SCIENTIFIC INC NYSE 152,699.905 41.315 41.619 5.3468 0.198
Global Peer DANAHER CORP NYSE 130,651.796 52.496 47.735 4.4356 0.362
Global Peer MEDTRONIC PLC NYSE 122,876.493 25.658 25.658 2.4218 2.357
Global Peer BECTON DICKINSON & CO NYSE 71,643.648 66.214 78.729 3.4199 1.170
Global Peer STRYKER CORP NYSE 68,132.486 32.709 31.485 5.1950 1.174
Global Peer INTUITIVE SURGICAL INC NASDAQ 67,750.393 49.119 48.871 7.9644 -
Global Peer BOSTON SCIENTIFIC CORP NYSE 49,362.622 10.503 11.514 3.5760 -
Global Peer BAXTER INTERNATIONAL INC NYSE 42,833.814 42.791 41.953 5.5636 1.004
Global Peer KONINKLIJKE PHILIPS NV ADR EACH REP 1 ORD EUR0.20 NYSE 42,960.931 32.891 32.891 3.0382 1.910
Other Global Peers EDWARDS LIFESCIENCES CORP (NYSE), DEXCOM INC (NASDAQ), IDEXX LABORATORIES INC (NASDAQ), ALCON AG (NYSE), RESMED INC (NYSE), ZIMMER BIOMET HOLDINGS INC (NYSE), GENMAB AS SPON ADS EACH REP 0.1 ORD SHS (NASDAQ), ALIGN TECHNOLOGY INC (NASDAQ), METTLER-TOLEDO INTERNATIONAL INC (NYSE), SMITH & NEPHEW ADR EACH REPR 2 ORD (NYSE), WEST PHARMACEUTICAL SERVICES INC (NYSE), TELEFLEX INC (NYSE), COOPER COS INC (NYSE), HOLOGIC INC (NASDAQ), BIO RAD LABORATORIES INC (NYSE), INSULET CORPORATION (NASDAQ), FISHER & PAYKEL HEALTHCARE CORP (ASX), HARTA (Bursa), TOPGLOV (Bursa), STERIS PLC (NYSE), Top Glove (SGX), MASIMO CORPORATION (NASDAQ), ABIOMED INC (NASDAQ), WATERS CORP (NYSE), PERKINELMER INC (NYSE), VARIAN MEDICAL SYSTEMS INC (NYSE), QIAGEN NV (NYSE), DENTSPLY SIRONA INC (NASDAQ), QUIDEL CORP (NASDAQ), COCHLEAR LTD (ASX), HILL-ROM HOLDINGS INC (NYSE), PENUMBRA INC (NYSE), BRUKER CORPORATION (NASDAQ), TANDEM DIABETES CARE INC (NASDAQ), NOVOCURE LTD (NASDAQ), HAEMONETICS CORP (NYSE), GLOBUS MED INC (NYSE), NEOGEN CORP (NASDAQ), INTEGRA LIFESCIENCES HLDGS CORP (NASDAQ), NEVRO CORP (NYSE), ICU MEDICAL INC (NASDAQ), WRIGHT MEDICAL GROUP NV (NASDAQ), INOVIO PHARMACEUTICALS INC (NASDAQ), ENVISTA HOLDINGS CORPORATION (NYSE), SUPERMX (Bursa), IRHYTHM TECHNOLOGIES INC (NASDAQ), NUVASIVE INC (NASDAQ), STAAR SURGICAL CO (NASDAQ), LIVANOVA PLC (NASDAQ), MERIT MEDICAL SYSTEMS (NASDAQ), INSPIRE MEDICAL SYSTEMS INC (NYSE), EBOS GROUP (ASX), INARI MEDICAL INC (NASDAQ), CONMED CORP (NYSE), ATRICURE INC (NASDAQ), CANTEL MEDICAL CORP (NYSE), CAREDX INC (NASDAQ), GLAUKOS CORPORATION (NYSE), SHOCKWAVE MEDICAL INC (NASDAQ), AXONICS MODULATION TECHNLOGS INC (NASDAQ), SILK ROAD MEDICAL INC (NASDAQ), AVANOS MEDICAL INC (NYSE), NANOSONICS LIMITED (ASX), BIOTELEMETRY INC (NASDAQ), CARDIOVASCULAR SYSTEMS INC DEL (NASDAQ), ATRION CORP (NASDAQ), CERUS CORP (NASDAQ), MESA LABORATORIES INC (NASDAQ), GENMARK DIAGNOSTICS INC (NASDAQ), VAPOTHERM INC (NYSE), INMODE LTD (NASDAQ), LANTHEUS HOLDINGS INC (NASDAQ), ORASURE TECHNOLOGIES INC (NASDAQ), ZYNEX INC (NASDAQ), HESKA CORP (NASDAQ), ACCELERATE DIAGNOSTICS INC (NASDAQ), INOGEN INC (NASDAQ), ORTHOPEDIATRICS CORP (NASDAQ), TACTILE SYSTEMS TECHNOLOGY INC (NASDAQ), CRYOLIFE INC (NYSE), NATUS MEDICAL INC (NASDAQ), VERICEL CORP (NASDAQ), AVITA THERAPEUTICS INC (NASDAQ), QUOTIENT LTD (NASDAQ), ORTHOFIX MEDICAL INC (NASDAQ), VAREX IMAGING CORPORATION (NASDAQ), SURMODICS INC (NASDAQ), BIOLIFE SOLUTIONS INC (NASDAQ), LEMAITRE VASCULAR INC (NASDAQ), INFUSYSTEM HOLDINGS INC (NYSE American), TRANSMEDICS GROUP INC (NASDAQ), CELLDEX THERAPEUTICS INC (NASDAQ), AVADEL PHARMACEUTICALS PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), SI BONE INC (NASDAQ), ANTARES PHARMA INC (NASDAQ), AXOGEN INC (NASDAQ), ESTABLISHMENT LABS HLDGS INC (NASDAQ), REPRO MEDSYSTEMS INC (NASDAQ), ANGIODYNAMICS INC (NASDAQ), CYTOSORBENTS CORP (NASDAQ), OXFORD IMMUNOTEC GLOBAL PLC (NASDAQ), MCP INCOME OPPORTUNITIES TRUST (ASX), CORMEDIX INC (NYSE American), MEDICAL DEVELOPMENT INTL (ASX), STEREOTAXIS INC (NYSE American), VIEWRAY INC (NASDAQ), FLUIDIGM CORP DEL (NASDAQ), UTAH MEDICAL PRODUCTS (NASDAQ), Medtecs Intl (SGX), PROFOUND MED CORP (NASDAQ), ALPHATEC HLDGS INC (NASDAQ), ITAMAR MEDICAL LTD SPON ADS EACH REP 30 ORD SHS (NASDAQ), IRADIMED CORP (NASDAQ), SEASPINE HOLDINGS CORP (NASDAQ), PULSE BIOSCIENCES INC (NASDAQ), ALPHA PRO TECH (NYSE American), VOLPARA HEALTH TECHNOLOGIES LTD (ASX), NYMOX PHARMACEUTICALS CORP(BAHAMAS) (NASDAQ), UG Healthcare (SGX), INVACARE CORP (NYSE), MISONIX INC (NASDAQ), CUTERA INC (NASDAQ), BIOSIG TECHNOLOGIES INC (NASDAQ), RTI SURGICAL HOLDINGS INC (NASDAQ), DERMTECH INC (NASDAQ), RETRACTABLE TECHNOLOGIES INC (NYSE American), SIENTRA INC (NASDAQ), TELA BIO INC (NASDAQ), ACCURAY INCORPORATED (NASDAQ), SOLITON INC (NASDAQ), APYX MEDICAL CORPORATION (NASDAQ), SOLENO THERAPEUTICS INC (NASDAQ), NEMAURA MEDICAL INC (NASDAQ), FONAR CORP (NASDAQ), ATOMO DIAGNOSTICS LIMITED (ASX), ROCKWELL MEDICAL INC (NASDAQ), BELLEROPHON THERAPEUTICS INC (NASDAQ), ELECTROMED INC (NYSE American), CELSION CORPORATION (NASDAQ), INTRICOM CORP (NASDAQ), VENUS CONCEPT INC (NASDAQ), PAVMED INC (NASDAQ), BIOMERICA INC (NASDAQ), VOLITIONRX LIMITED (NYSE American), CYCLOPHARM LIMITED (ASX), RESAPP HEALTH LIMITED (ASX), CHEMBIO DIAGNOSTICS INC (NASDAQ), NEPHROS INC (NASDAQ), ENLIVEX THERAPEUTICS LTD (NASDAQ), EMVISION MEDICAL DEVICES LTD (ASX), SOMNOMED LIMITED (ASX), NOVA EYE MEDICAL LIMITED (ASX), MILESTONE SCIENTIFIC INC (NYSE American), DAXOR CORP (NYSE American), BRAINSWAY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), COLLPLANT BIOTECHNOLOGIES LTD SPON ADS EACH REP 1 ORD SHS (NASDAQ), LKL (Bursa), Biolidics (SGX), CONFORMIS INC (NASDAQ), SDI LTD (ASX), CLEARPOINT NEURO INC (NASDAQ), EKSO BIONICS HOLDINGS INC (NASDAQ), TRINITY BIOTECH PLC ADR EACH REPR 4 CLS A ORD USD0.019 (NASDAQ), COMPUMEDICS (ASX), TITAN MEDICAL INC (NASDAQ), IMPEDIMED LIMITED (ASX), DIMERIX LTD (ASX), RESONANCE HEALTH LTD (ASX), SENSUS HEALTHCARE INC (NASDAQ), RESPIRI LTD (ASX), ALLIED HEALTHCARE PRODUCTS INC (NASDAQ), ZOSANO PHARMA CORP (NASDAQ), OSPREY MEDICAL INC NPV (CHESS DEPOSITARY INTERESTS) (ASX), IMMUCELL CORP (NASDAQ), HELIUS MEDICAL TECHNOLOGIES INC (NASDAQ), ONCOCYTE CORP (NYSE American), STRATA SKIN SCIENCES INC (NASDAQ), NEOVASC INC (NASDAQ), SINTX TECHNOLOGIES INC (NASDAQ), MOTUS GI HOLDINGS INC (NASDAQ), NEURONETICS INC (NASDAQ), MICRO-X LTD (ASX), APOLLO ENDOSURGERY INC (NASDAQ), THERMOGENESIS HOLDINGS INC (NASDAQ), DELCATH SYSTEMS INC (NASDAQ), ELECTROCORE INC (NASDAQ), ATOSSA THERAPEUTICS INC (NASDAQ), IRIDEX CORP (NASDAQ), Yunnan Energy (SGX), OVENTUS MEDICAL LTD (ASX), LBT INNOVATIONS LTD (ASX), INCANNEX HEALTHCARE LTD (ASX), UNIVERSAL BIOSENSORS INC NPV (CDI) (ASX), NEUROTROPE INC (NASDAQ), METALICITY LIMITED (ASX), USCOM LTD (ASX), DARIOHEALTH CORP (NASDAQ), REWALK ROBOTICS LTD (NASDAQ), ALLEGRA ORTHOPAEDICS LIMITED (ASX), CHF SOLUTIONS INC (NASDAQ), BIOLASE INC (NASDAQ), IMAGION BIOSYSTEMS LIMITED (ASX), SECOND SIGHT MEDICAL PRODUCTS INC (NASDAQ), AKERS BIOSCIENCES INC (NASDAQ), NANOVIBRONIX INC (NASDAQ), LIANLUO SMART LIMITED (NASDAQ), PREDICTIVE ONCOLOGY INC (NASDAQ), AVINGER INC (NASDAQ), XTANT MEDICAL HLDGS INC (NYSE American), AETHLON MEDICAL INC (NASDAQ), MYOS RENS TECHNOLOGY INC (NASDAQ), CHECK-CAP LTD (NASDAQ), RA MEDICAL SYSTEMS INC (NYSE), DIGIRAD CORP (NASDAQ), OPTISCAN IMAGING (ASX), CYANOTECH CORP (NASDAQ), CARDIEX LTD (ASX), DYNATRONICS CORP (NASDAQ), Annica (SGX), ADHERIUM LIMITED (ASX), VIVEVE MEDICAL INC (NASDAQ), HANCOCK JAFFE LABORATORIES INC (NASDAQ), TENAX THERAPEUTICS INC (NASDAQ), CANCER GENETICS INC (NASDAQ), ENDOLOGIX INC (NASDAQ), NEUROMETRIX INC (NASDAQ), OBALON THERAPEUTICS INC (NASDAQ), STHAI (SET), ANALYTICA (ASX), DORSAVI LTD (ASX), INSPIREMD INC (NYSE American), MEDIGARD LIMITED (ASX), NEUROTECH INTERNATIONAL LTD (ASX), MEDIGUS SPON ADS EACH REP 50 ORD SHS (POST SPLT) (NASDAQ)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --0.030
-1.54 %
10 Days -+0.020
+1.05 %
20 Days --0.080
-4.00 %
Medium Term Return 3 Months --0.750
-28.09 %
6 Months --1.050
-35.35 %
1 Year --1.180
-38.06 %
Long Term Return 2 Years --2.010
-51.15 %
3 Years -+0.190
+10.98 %
5 Years --0.480
-20.00 %
Annualised Return Annualised --
-4.36 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 1.700 - 3.460 Change From 1 Year Low +0.220 % Change From 1 Year Low (%) +12.94
Change From 1 Year High -1.540 % Change From 1 Year High (%) -44.51
2 Years Range 1.700 - 4.050 Change From 2 Years Low +0.220 % Change From 2 Years Low (%) +12.94
Change From 2 Years High -2.130 % Change From 2 Years High (%) -52.59
5 Years Range 1.070 - 5.200 Change From 5 Years Low +0.850 % Change From 5 Years Low (%) +79.44
Change From 5 Years High -3.280 % Change From 5 Years High (%) -63.08
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Yunnan Energy International Co. Ltd. engages in the design, manufacture, and sale of life science equipment and laboratory instruments. It operates through Distribution and Manufacturing segments. The Distribution segment distributes laboratory, analytical, and life science devices. The Manufacturing segment develops and sells life science instruments and equipment. The company was founded on January 26, 2004 and is headquartered in Hong Kong.

Historical Price Data

Date Open High Low Close Volume VWAP
08 Jul 2020 1.920 1.920 1.920 1.920 - -
07 Jul 2020 1.940 1.940 1.940 1.940 - -
06 Jul 2020 1.950 1.950 1.950 1.950 - -
02 Jul 2020 1.950 1.950 1.950 1.950 70,000 1.9500
30 Jun 2020 1.850 1.850 1.840 1.840 2,000 1.8500
29 Jun 2020 1.800 1.800 1.800 1.800 8,000 1.8000
26 Jun 2020 1.900 1.900 1.900 1.900 - -
24 Jun 2020 1.900 1.900 1.900 1.900 - -
23 Jun 2020 1.900 1.900 1.900 1.900 280,000 1.9000
22 Jun 2020 1.700 2.000 1.700 2.000 15,000 1.8320
19 Jun 2020 2.000 2.000 2.000 2.000 - -
18 Jun 2020 2.000 2.000 2.000 2.000 - -
17 Jun 2020 2.000 2.000 2.000 2.000 - -
16 Jun 2020 2.000 2.000 2.000 2.000 - -
15 Jun 2020 2.000 2.000 2.000 2.000 - -
12 Jun 2020 2.000 2.000 2.000 2.000 - -
11 Jun 2020 2.000 2.000 2.000 2.000 - -
10 Jun 2020 2.000 2.100 2.000 2.000 9,000 2.0333
09 Jun 2020 1.900 1.900 1.900 1.900 - -
08 Jun 2020 1.900 1.900 1.900 1.900 - -
05 Jun 2020 1.900 1.900 1.900 1.900 8,000 1.9000
04 Jun 2020 1.820 1.820 1.820 1.820 - -
Summary
Current 2 Weeks
(22 Jun 2020 to 08 Jul 2020)
1.700 2.000 1.700 1.920 375,000 -
Previous 2 Weeks
(08 Jun 2020 to 19 Jun 2020)
1.900 2.000 1.700 2.000 9,000 -
4 Weeks from
(11 May 2020 to 05 Jun 2020)
2.000 2.000 1.700 1.900 86,000 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.